Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study

Autor: Calabrò, Luana, Morra, Aldo, Fonsatti, Ester, Cutaia, Ornella, Fazio, Carolina, Annesi, Diego, Lenoci, Marica, Amato, Giovanni, Danielli, Riccardo, Altomonte, Maresa, Giannarelli, Diana, Di Giacomo, Anna Maria, Maio, Michele
Zdroj: In The Lancet Respiratory Medicine April 2015 3(4):301-309
Databáze: ScienceDirect